U.S. markets closed

Phreesia, Inc. (PHR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
51.10-0.32 (-0.62%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close51.42
Open51.85
Bid51.10 x 900
Ask51.18 x 1000
Day's Range50.18 - 52.36
52 Week Range20.55 - 81.59
Volume236,618
Avg. Volume503,991
Market Cap2.559B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.69
Earnings DateJun 07, 2021 - Jun 11, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est64.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    Business Wire

    Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

    Phreesia, Inc. (the "Company") (NYSE:PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,175,000 shares of its common stock (the "Offering") all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 675,000 additional shares of common stock. The shares were sold at a public offering price of $50.00 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount.

  • Phreesia Announces Pricing of Public Offering of Common Stock
    Business Wire

    Phreesia Announces Pricing of Public Offering of Common Stock

    Phreesia, Inc. ("Phreesia") (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock (the "Offering") at a price to the public of $50.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts.

  • Phreesia Announces Proposed Public Offering of Common Stock
    Business Wire

    Phreesia Announces Proposed Public Offering of Common Stock

    Phreesia, Inc. ("Phreesia") (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 4,500,000 shares of its common stock (the "Offering"), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is subject to market and other conditions, and there can be no assurances as to whether or when the Offering may be completed, or as to the actual size and terms of the offering.